PAZCOVRI
Live / Allowed — Notice of allowance issued (as of 02 Dec 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 09 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99225392
- Mark type
- Stylized text
- Filed
- 09 Jun 2025
- Published for opposition
- 07 Oct 2025
- Attorney of record
- Tiffany Trunko
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 02 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Oct 2025 — PUBLISHED FOR OPPOSITION
- 01 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Sept 2025 — ASSIGNED TO EXAMINER
- 04 Sept 2025 — ASSIGNED TO EXAMINER
- 09 Jun 2025 — APPLICATION FILING RECEIPT MAILED
- 09 Jun 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 09 Jun 2025 — NEW APPLICATION ENTERED